【结 构 式】 |
【分子编号】40926 【品名】2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide 【CA登记号】 |
【 分 子 式 】C12H11BrN2O2 【 分 子 量 】295.13562 【元素组成】C 48.84% H 3.76% Br 27.07% N 9.49% O 10.84% |
合成路线1
该中间体在本合成路线中的序号:(III)Condensation of 5-bromoindole (I) with oxalyl chloride produced (5-bromo-3-indolyl)glyoxyl chloride (II), which was subsequently treated with dimethylamine to give amide (III). Conversion of (III) to the tributylstannyl derivative (IV) was achieved by reaction with hexabutylditin in the presence of tetrakis(triphenylphosphine) palladium in refluxing dimethoxyethane. Palladium-catalyzed coupling of stannyl indole (IV) with 5-bromo-2-thiophenecarboxaldehyde (V) furnished the thienyl indole (VI). Finally, reduction of (VI) with LiAlH4 in boiling THF produced a mixture of the desired 5-methylthiophene derivative along with the 5-(hydroxymethyl) analogue (VII), that were separated by column chromatography.
【1】 Kamboj, R.; Slassi, A.; Mazzocco, L.; Meng, C.Q.; Lee, D.K.H.; Dyne, K.; McCallum, K.L.; Rakhit, S.; 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine. Bioorg Med Chem Lett 2000, 10, 9, 903. |
【2】 Meng, Q.; Slassi, A.; Rakhit, S. (NPS Allelix Corp.); Thiophene- and furan-tryptamine derivs.. WO 9743281 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13309 | 5-Bromo-1H-indole; 5-Bromoindole | 10075-50-0 | C8H6BrN | 详情 | 详情 |
(II) | 40925 | 2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl chloride | C10H5BrClNO2 | 详情 | 详情 | |
(III) | 40926 | 2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide | C12H11BrN2O2 | 详情 | 详情 | |
(IV) | 40927 | N,N-dimethyl-2-oxo-2-[5-(tributylstannyl)-1H-indol-3-yl]acetamide | C24H38N2O2Sn | 详情 | 详情 | |
(V) | 40928 | 5-bromo-2-thiophenecarbaldehyde | 4701-17-1 | C5H3BrOS | 详情 | 详情 |
(VI) | 40929 | 2-[5-(5-formyl-2-thienyl)-1H-indol-3-yl]-N,N-dimethyl-2-oxoacetamide | C17H14N2O3S | 详情 | 详情 | |
(VII) | 40930 | (5-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-2-thienyl)methanol | C17H20N2OS | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)Condensation between 5-bromoindole (I) in ether and oxalyl chloride (II) in dichloromethane followed by treatment with dimethylamine provides N,N-dimethyaminoglyoxyl derivative (III), which is then reduced with LiAlH4 in THF to yield compound (IV). Coupling of (IV) with benzoyl chloride (V) by means of Et3N and DMAP in dichloromethane affords benzoylindole derivative (VI), which is then subjected to reaction with tributylstannyl derivative (VII) in toluene in the presence of Pd(PPh3)4 to furnish compound (VIII). Treatment of (VIII) with NaOH in refluxing MeOH gives indole (IX), which is converted into the final product by reduction with LiAlH4 in refluxing THF) and treatment with HCl for the formation of the corresponding hydrochloride salt. Alternatively, the target compound can be obtained as follows: treatment of (IV) with KH in ether and tert-butyllithium in pentane followed by reaction with N-methylpiperidinone (X) affords hydroxy derivative (XI), which is finally converted into the desired product.
【1】 Arora, J.; et al.; 5-Bicyclopiperidinetryptamine derivatives as selective 5-HT1D agonists. Soc Neurosci Abst 2000, 26, Part 1, Abst 145.14. |
【2】 Slassi, A.; Edwards, L.; Meng, Q.; Rakhit, S. (NPS Allelix Corp.); 5-Cyclo indole cpds. as 5-HT1D receptor ligands. EP 0944595; JP 2001504501; WO 9823587 . |
【3】 Rakhit, S.; Edwards, L.; Slassi, A.; Meng, Q. (NPS Allelix Corp.); 5-Cyclo indole cpds.. US 5998438 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13309 | 5-Bromo-1H-indole; 5-Bromoindole | 10075-50-0 | C8H6BrN | 详情 | 详情 |
(II) | 29841 | Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride | 79-37-8 | C2Cl2O2 | 详情 | 详情 |
(III) | 40926 | 2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide | C12H11BrN2O2 | 详情 | 详情 | |
(IV) | 49717 | N-[2-(5-bromo-1H-indol-3-yl)ethyl]-N,N-dimethylamine; 2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-1-ethanamine | C12H15BrN2 | 详情 | 详情 | |
(V) | 10463 | Benzoyl chloride | 98-88-4 | C7H5ClO | 详情 | 详情 |
(VI) | 49718 | [5-bromo-3-[2-(dimethylamino)ethyl]-1H-indol-1-yl](phenyl)methanone | C19H19BrN2O | 详情 | 详情 | |
(VII) | 49719 | tert-butyl 4-(tributylstannyl)-3,6-dihydro-1(2H)-pyridinecarboxylate | C22H43NO2Sn | 详情 | 详情 | |
(VIII) | 49720 | tert-butyl 4-[1-benzoyl-3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-3,6-dihydro-1(2H)-pyridinecarboxylate | C29H35N3O3 | 详情 | 详情 | |
(IX) | 49721 | tert-butyl 4-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-3,6-dihydro-1(2H)-pyridinecarboxylate | C22H31N3O2 | 详情 | 详情 | |
(X) | 10919 | 1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one | 1445-73-4 | C6H11NO | 详情 | 详情 |
(XI) | 49722 | 4-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-1-methyl-4-piperidinol | C18H27N3O | 详情 | 详情 |